Novavax, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2020
Total Assets: $1.58B
Liabilities Breakdown FY2020
Total Liabilities: $955.3M
Asset Breakdown
Total Assets: $1.58B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $553.4M | 35.0% |
| Accounts Receivable | $262.0M | 16.6% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $180.0M | 11.4% |
| Goodwill | $135.4M | 8.6% |
| Intangible Assets | $5.7M | 0.4% |
| Other Assets | $446.0M | 28.2% |
Liabilities Breakdown
Total Liabilities: $955.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $54.3M | 5.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $900.9M | 94.3% |